Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Globelmmune Inc (CE) (GBIM)
Globelmmune Inc (CE) (GBIM) Actualités

GBIM

Globelmmune (CE) (GBIM)

Globelmmune Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:GBIM

1

Date	Heure	Source	Titre	Symbole	Société
23/03/2017	22h23	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:GBIM	Globelmmune Inc (CE)
15/07/2016	22h19	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:GBIM	Globelmmune Inc (CE)
15/07/2016	22h11	Edgar (US Regulatory)	(25)	USOTC:GBIM	Globelmmune Inc (CE)
05/07/2016	22h44	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GBIM	Globelmmune Inc (CE)
20/06/2016	17h15	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:GBIM	Globelmmune Inc (CE)
12/05/2016	12h21	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:GBIM	Globelmmune Inc (CE)
28/04/2016	22h22	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:GBIM	Globelmmune Inc (CE)
18/03/2016	23h12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:GBIM	Globelmmune Inc (CE)
24/02/2016	18h07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:GBIM	Globelmmune Inc (CE)
16/02/2016	22h31	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:GBIM	Globelmmune Inc (CE)
22/05/2015	22h22	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:GBIM	Globelmmune Inc (CE)
22/05/2015	22h17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:GBIM	Globelmmune Inc (CE)
10/04/2015	22h21	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:GBIM	Globelmmune Inc (CE)
17/03/2015	21h19	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:GBIM	Globelmmune Inc (CE)
05/09/2014	22h46	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:GBIM	Globelmmune Inc (CE)
17/07/2014	19h57	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:GBIM	Globelmmune Inc (CE)
08/07/2014	23h00	GlobeNewswire Inc.	GlobeImmune Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Overallotment Option	USOTC:GBIM	Globelmmune Inc (CE)
02/07/2014	23h11	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	USOTC:GBIM	Globelmmune Inc (CE)
02/07/2014	23h06	Edgar (US Regulatory)	Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)	USOTC:GBIM	Globelmmune Inc (CE)
02/07/2014	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:GBIM	Globelmmune Inc (CE)
02/07/2014	00h14	GlobeNewswire Inc.	GlobeImmune Announces Pricing of Initial Public Offering	USOTC:GBIM	Globelmmune Inc (CE)
02/07/2014	00h00	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:GBIM	Globelmmune Inc (CE)
11/11/2012	13h30	GlobeNewswire	GI-5005 Improves Virologic Clearance of HCV in Combination with PegIFN/Ribavirin in IL28B T/T Patients	USOTC:GBIM	Globelmmune Inc (CE)
10/11/2012	13h59	GlobeNewswire	GI-13020 Tarmogen® for the Treatment of Chronic Hepatitis B Generates Antigen-specific T Cell Responses in Key Preclinical S...	USOTC:GBIM	Globelmmune Inc (CE)
20/09/2012	00h00	Dow Jones News	Five IPO Pricings to Break Market's Lull	USOTC:GBIM

Showing the most relevant articles for your search:USOTC:GBIM

1

TRU Precious Metals (PK)

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales